Drug-labels.com

Teva-Galantamine ER: Uses, Side Effects and Dosage

Status:
Prescription (Rx) Current status: Cancelled Post Market Facts
Strength:
8 mg, 16 mg, 24 mg

Patient Medication Information: uses, side effects, how to take - Teva-Galantamine ER

ABOUT THIS MEDICATION

What the medication is used for:

TEVA-GALANTAMINE ER is used to treat the symptoms of mild to moderate Alzheimer’s disease (a type of dementia), a disease that alters brain function. The symptoms include progressive memory loss, increasing confusion and behavioural changes, as a result of which it becomes more and more difficult to carry out the activities of daily living.

What it does:

This medication is one of a group of drugs called “cholinesterase inhibitors” which are used to treat the symptoms of mild to moderate Alzheimer’s disease.

Dementia due to Alzheimer’s disease is believed to be related to lack of a substance in the brain called acetylcholine, a substance which is thought to be necessary for good brain function. TEVA-GALANTAMINE ER increases the amount of this substance in the brain, improving memory.

When it should not be used:

  • If you/the person you are caring for has an allergic reaction to this medicine or to any of the inactive ingredients in this product
  • If you/the person you are caring for has ever had an allergic reaction to a similar type of medicine
  • If you/the person you are caring for is a child under 18 years of age

  • Unless you/the person you are caring for has been diagnosed with Alzheimer’s disease

What the medicinal ingredient is:

galantamine hydrobromide

What the nonmedicinal ingredients are:

TEVA-GALANTAMINE ER extended release capsules: Gelatin, ethylcellulose, hypromellose, polyethylene glycol, titanium dioxide, triethyl citrate, sugar spheres (sucrose and starch), printing ink Opacode Black 1028 (iron oxide black, propylene glycol and shellac glaze), printing ink TekPrintTMSW-9008 Black Ink 1014 (iron oxide black, propylene glycol and shellac glaze). The 16 mg capsule also contains erythrosine and quinoline yellow (E104). The 24 mg capsule also contains iron oxide red and iron oxide yellow.

What dosage forms it comes in:

Extended release capsules: 8 mg, 16 mg, 24 mg

WARNINGS AND PRECAUTIONS

BEFORE you use TEVA-GALANTAMINE ER, talk to your doctor or pharmacist if you have any of the following problems or conditions:

  • heart disorders
  • stomach ulcer or history of ulcer
  • acute abdominal pain
  • some disorders of the nervous system (like epilepsy)
  • respiratory diseases that interfere with breathing (like asthma)
  • a recent operation on the gut or bladder or difficulties in passing urine
  • an increased risk of developing ulcers (for example, you are taking non-steroidal anti-inflammatory drugs (NSAIDs) or high doses of acetylsalicylic acid [ASA (Aspirin®)]
  • liver or kidney problems
  • pregnant or possibly pregnant

  • breast-feeding
  • having an operation with general anesthesia (medication that puts you to sleep)
  • taking any other medications, including prescription, over-the-counter, herbal medicines or natural health products

If any of these happen after you start taking your medication, make sure you tell your doctor.

TEVA-GALANTAMINE ER, as well as Alzheimer’s disease itself, can affect the ability to drive or operate machinery. Therefore, this matter should be discussed with your doctor.

INTERACTIONS WITH THIS MEDICATION

Always tell your doctor, nurse or pharmacist if you are taking any other medicines, either prescription, over-the counter, herbal medicines, or natural health products, because taking some medicines together can be harmful.

Tell your doctor if you are taking:

  • drugs for diarrhea, Parkinson’s disease, or airway spasms
  • drugs for certain heart problems, such as digoxin
  • certain drugs taken for depression such as paroxetine
  • ketoconazole, a drug used to treat fungal infections

PROPER USE OF THIS MEDICATION

Usual dose:

TEVA-GALANTAMINE ER is started at a low dose and then slowly increased to the most suitable dose, depending on how you respond to the treatment. TEVA-GALANTAMINE ER extended release capsules should be taken once a day in the morning, preferably with food. Be sure to drink plenty of liquids during your treatment to keep yourself hydrated.

REMEMBER: This medicine is for you. Only a doctor can prescribe it for you. Never give it to someone else. It may harm them even if their symptoms appear to be similar to yours.

Overdose:

In the case of overdose, contact a health care practitioner, hospital emergency department of regional Poison Control Centre immediately, even if there are no symptoms.

Missed dose:

If you forget to take a dose, do not worry, wait and take the next dose at the usual time. Do NOT take two doses at once.

If your treatment is interrupted for several days or longer, do NOT re-initiate treatment without contacting your doctor.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

If side effects occur, they are mainly experienced early in the treatment or when the dose is increased. Most tend to disappear gradually as the body adapts to the treatment; for example, nausea (feeling sick) and vomiting (being sick) generally pass after a few days. However, you should tell your doctor about any side effects, especially if they persist.

Other possible side effects include:

  • abdominal pain, diarrhea, indigestion, decreased appetite
  • difficulty swallowing
  • bleeding in the digestive system
  • weight loss
  • low blood potassium
  • low blood pressure
  • dehydration (sometimes severe)
  • behavioural disturbances like agitation, aggression and hallucinations
  • weakness
  • fever
  • malaise
  • leg cramps
  • tingling in the hands or feet
  • ringing in the ears
  • headache
  • dizziness
  • tiredness, sleepiness or sleeplessness
  • confusion
  • runny nose
  • sweating
  • urinary tract infection, incontinence
  • falling, sometimes resulting in injury

    • fainting and fluttering of the heart
    • trembling
    • heart rhythm disorder
    • slow heartbeat
    • heart attack
    • stroke
    • other side effects described below

SERIOUS SIDE EFFECTS, HOW OFTEN THEY

HAPPEN AND WHAT TO DO ABOUT THEM

Symptom / effectSeek medical attention immediatelyStop taking drug and call your doctor or pharmacist
Only if severeIn all cases
Uncommon

Irregular beating of

the heart

√

Pain or tightness in

the chest

√
Seizures√

Sudden weakness

or numbness of the

face, arms or legs,

especially on one

side, slurred

speech or vision

problems

√
Rare

Symptoms of

allergic reaction

such as skin rash,

or swelling of the

face, lips or tongue

√

Thoughts of

suicide or self-harm

√
Very Rare

Blood in the stools,

black, tarry stools,

or vomiting blood

√

If you are caring for a patient with Alzheimer's disease who has new symptoms you should discuss them with his or her doctor.

If you feel unwell in the ways described in this section or any other way, or have any symptoms that you do not understand or find distressing, you should contact your doctor immediately. If you experience side effects that are severe, stop taking the drug and contact your doctor immediately.

This is not a complete list of side effects. For any unexpected effects while taking TEVA-GALANTAMINE ER, contact your doctor or pharmacist.

HOW TO STORE IT

As with all medicines, TEVA-GALANTAMINE ER should be kept in a safe place where children cannot reach it. Also keep this medicine in a cool dry place (15 to 30°C).

Medicines can be kept for a limited period only. Therefore, do not use TEVA-GALANTAMINE ER after the date

(month and year) printed after “EXP”, even if it has been stored properly. Always return old medicines to your pharmacist.

REPORTING SUSPECTED SIDE EFFECTS You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:

  • Report online at

www.healthcanada.gc.ca/medeffect

  • Call toll-free at 1-866-234-2345
  • Complete a Canada Vigilance Reporting Form and:
  • Fax toll-free to 1-866-678-6789, or
  • Mail to:

    Canada Vigilance Program Health Canada

    Postal Locator 0701E

    Ottawa, ON

    K1A 0K9

Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffect™ Canada Web site at www.healthcanada.gc.ca/medeffect.

NOTE: Should you require information related to the management of the side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice.

  • •

MORE INFORMATION

Please consult your doctor or pharmacist with any questions or concerns you may have regarding your individual condition.

This document plus the full product monograph, prepared for health professionals can be found by contacting Teva Canada Limited.

at: 1-800-268-4127 ext. 5005 (English)

and at 1-877-777-9117 (French)

or druginfo@tevacanada.com

Teva Canada Limited

30 Novopharm Court

Toronto, Ontario

Canada, M1B 2K9

www.tevacanada.com

Date: September 3, 2014

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02377950

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Teva-Galantamine ER

Rx or OTC
Prescription (Rx)?
DIN 02377950, 02377969, 02377977
Schedule(s) PRESCRIPTION
Active ingredient(s) Galantamine (galantamine hydrobromide)
Dosage form(s) Capsule (Extended-Release)
Route(s) of administration Oral
Drug class (WHO ATC)
  1. N Nervous system drugs
    1. N06 Psychoanaleptics
      1. N06D Anti-dementia drugs
        1. N06DA Anticholinesterase anti-dementia drugs
          1. N06DA04 Galantamine
Company TEVA CANADA LIMITED
Current status Cancelled Post Market
Current status date June 22, 2018
Strengths and forms
DIN Strength Dosage form(s) Current status
02377950 8 MG Capsule (Extended-Release) Cancelled Post Market June 22, 2018
02377969 16 MG Capsule (Extended-Release) Cancelled Post Market June 22, 2018
02377977 24 MG Capsule (Extended-Release) Cancelled Post Market June 22, 2018

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.